1.A case of emphysematous hepatitis with spontaneous pneumoperitoneum in a patient with hilar cholangiocarcinoma.
Jung Ho KIM ; Eul Sik JUNG ; Seok Hoo JEONG ; Ju Seung KIM ; Yang Suh KU ; Ki Baik HAHM ; Ju Hyun KIM ; Yeon Suk KIM
The Korean Journal of Hepatology 2012;18(1):94-97
An 80-year-old woman with hilar cholangiocarcinoma was hospitalized due to sudden-onset abdominal pain. Computed tomography revealed hepatic necrosis accompanied with emphysematous change in the superior segment of the right liver (S7/S8), implying spontaneous rupture, based on the presence of perihepatic free air. Although urgent percutaneous drainage was performed, neither pus nor fluids were drained. These findings suggest emphysematous hepatitis with a hepatic mass. Despite the application of intensive care, the patient's condition deteriorated rapidly, and she died 3 days after admission to hospital. Liver gas has been reported in some clinical diseases (e.g., liver abscess) to be caused by gas-forming organisms; however, emphysematous hepatitis simulating emphysematous pyelonephritis is very rare. The case reported here was of fatal emphysematous hepatitis in a patient with hilar cholangiocarcinoma.
Aged, 80 and over
;
Anti-Bacterial Agents/therapeutic use
;
Bile Duct Neoplasms/complications/diagnosis
;
Bile Ducts, Intrahepatic/pathology
;
Cefotaxime/therapeutic use
;
*Cholangiocarcinoma/complications/diagnosis
;
Clostridium Infections/drug therapy/microbiology
;
Clostridium perfringens/isolation & purification
;
Emphysema/complications/*diagnosis
;
Escherichia coli/isolation & purification
;
Escherichia coli Infections/drug therapy/microbiology
;
Female
;
Hepatitis/complications/*diagnosis
;
Humans
;
Metronidazole/therapeutic use
;
*Pneumoperitoneum/complications/diagnosis
;
Tomography, X-Ray Computed
2.Effect of Pneumoperitoneum on Oxidative Stress and Inflammation via the Arginase Pathway in Rats.
Seokyung SHIN ; Sungwon NA ; Ok Soo KIM ; Yong Seon CHOI ; Shin Hyung KIM ; Young Jun OH
Yonsei Medical Journal 2016;57(1):238-246
PURPOSE: Oxidative stress during CO2 pneumoperitoneum is reported to be associated with decreased bioactivity of nitric oxide (NO). However, the changes in endothelial nitric oxide synthase (eNOS), inducible nitric oxide synthase (iNOS), and arginase during CO2 pneumoperitoneum have not been elucidated. MATERIALS AND METHODS: Thirty male Sprague-Dawley rats were randomized into three groups. After anesthesia induction, the abdominal cavities of the rats of groups intra-abdominal pressure (IAP)-10 and IAP-20 were insufflated with CO2 at pressures of 10 mm Hg and 20 mm Hg, respectively, for 2 hours. The rats of group IAP-0 were not insufflated. After deflation, plasma NO was measured, while protein expression levels and activity of eNOS, iNOS, arginase (Arg) I, and Arg II were analyzed with aorta and lung tissue samples. RESULTS: Plasma nitrite concentration and eNOS expression were significantly suppressed in groups IAP-10 and IAP-20 compared to IAP-0. While expression of iNOS and Arg I were comparable between the three groups, Arg II expression was significantly greater in group IAP-20 than in group IAP-0. Activity of eNOS was significantly lower in groups IAP-10 and IAP-20 than in group IAP-0, while iNOS activity was significantly greater in group IAP-20 than in groups IAP-0 and IAP-10. Arginase activity was significantly greater in group IAP-20 than in groups IAP-0 and IAP-10. CONCLUSION: The activity of eNOS decreases during CO2 pneumoperitoneum, while iNOS activity is significantly increased, a change that contributes to increased oxidative stress and inflammation. Moreover, arginase expression and activity is increased during CO2 pneumoperitoneum, which seems to act inversely to the NO system.
Animals
;
Aorta/*physiology
;
Arginase/*antagonists & inhibitors
;
Enzyme Inhibitors/administration & dosage/pharmacology
;
Inflammation/etiology/*prevention & control
;
Injections, Subcutaneous
;
Lung Injury/etiology/prevention & control
;
Male
;
Nitric Oxide/metabolism
;
Nitric Oxide Synthase Type II/*metabolism
;
Nitric Oxide Synthase Type III/*metabolism
;
Oxidative Stress/*drug effects
;
Pneumoperitoneum/*complications/drug therapy
;
Rats
;
Rats, Sprague-Dawley